SCHEMBL6789308

SCHEMBL6789308

COc1ccc2ccccc2c1C1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.58
ALDH1A1 P00352 2/20 0.54
HTR1A P08908 2/20 0.54
HTR7 P34969 2/20 0.54
MEN1 O00255 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
ALOX12 P18054 1/20 0.54
ADRA1D P25100 1/20 0.54
ADRA1A P35348 1/20 0.54
ADRA1B P35368 1/20 0.54
KMT2A Q03164 1/20 0.54
HIF1A Q16665 1/20 0.54
HSD17B10 Q99714 1/20 0.54
KDM4E B2RXH2 1/20 0.53
GLA P06280 1/20 0.53
HPGD P15428 1/20 0.53
DRD3 P35462 4/20 0.52
HTR2A P28223 1/20 0.51
HTR6 P50406 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6790827 0.84 SLC6A4 (0.48) DRD2MEN1KMT2A
SCHEMBL6728261 0.83 DRD2 (0.53) DRD2ALDH1A1HTR1AHTR7MEN1
SCHEMBL6784248 0.81 MTNR1A (0.44) DRD2ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL6709174 0.79 DRD2 (0.61) DRD2HTR1AHTR7ADRA1DADRA1A
SCHEMBL6710692 0.78 DRD2 (0.49) DRD2ALDH1A1HTR1AHTR7ADRA1D
SCHEMBL8042421 0.77 DRD2 (0.63) DRD2ALDH1A1HTR1AHTR7MEN1
SCHEMBL8042425 0.77 DRD2 (0.63) DRD2ALDH1A1HTR1AHTR7MEN1
SCHEMBL6707980 0.76 DRD2 (0.56) DRD2ALDH1A1HTR1AHTR7MEN1
SCHEMBL6784585 0.76 DRD2 (0.49) DRD2HTR1AHTR7DRD3HTR2A
SCHEMBL6709241 0.76 HTR1A (0.62) DRD2ALDH1A1HTR1AHTR7MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040147557-A1 Aryl piperidine derivatives as inducers of ldl-receptor expression BOUILLOT ANNE (FR) 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147557-A1 Aryl piperidine derivatives as inducers of ldl-receptor expression NR1H2, NR1H3, NR1H4 DRD2 152/4885ALDH1A1 1002/4885HTR1A 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.